ProQR's CEO at #ASGCT2024 on NHP proof-of-concept data for the company's Axiomer RNA-editing platform
Daniel de Boer describes how Axiomer harnesses the body's natural ADAR editing process to turn an A into an I, he covers NHP data for cholestatic diseases presented at ASGCT, and highlights other potential use cases.